Harold H. Shlevin, Director at GALECTIN THERAPEUTICS INC (GALT), sold 44,292 shares at $7.04 ($312K) on 2025-12-17, disclosed to the SEC on 2025-12-19.
Scheduled sale ($312k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.04 | 4,706 | $33K | 10.6% |
| 2 | $7.04 | 19,793 | $139K | 44.7% |
| 3 | $7.04 | 19,793 | $139K | 44.7% |
| Total | $7.04 avg | 44,292 | $312K | 100% |
| Filing → |
| GALT | SELL | 2025-12-10 | $1.3M | — | Filing → |
| GALT | BUY | 2024-12-31 | $8K | — | Filing → |
| GALT | SELL | 2018-06-14 | $565K | — | Filing → |